<DOC>
	<DOCNO>NCT02520635</DOCNO>
	<brief_summary>The primary purpose study evaluate efficacy safety supra-early post-surgery chemotherapy versus standard TEMODALÂ® regimen treatment patient newly diagnose glioblastoma multiforme . The secondary purpose assess efficacy supra-early post-surgery chemotherapy release brain edema .</brief_summary>
	<brief_title>Supra-early Post-Surgery Chemotherapy Treatment GBM Patients</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>1 . Patients prior histological confirmation newly diagnose primary glioblastoma multiforme supratentorial cerebral hemisphere . 2 . Gross total resection partial resection ( image ) &gt; 70 % . 3 . Chemoradiotherapy expect Week 5 ( Day 29 ) surgery . 4 . Age &gt; =18 &lt; =70 year . 5 . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 . 6 . Life expectancy &gt; =9 month . 7 . Laboratory test value must satisfy follow criterion : 1. absolute neutrophil count &gt; =1.5 x 10^9/L ; 2. platelet count &gt; =100 x 10^9/L ; 3. hemoglobin &gt; =80 g/L ; 4. blood urea nitrogen creatinine &lt; 1.5 x upper limit normal value ( ULN ) ; 5. total bilirubin direct bilirubin &lt; 1.5 x ULN ; 6. alanine aminotransferase aspartate aminotransferase &lt; 3 x ULN ; 7. alkaline phosphatase &lt; 2 x ULN . 8 . Patients must willing provide write informed consent . 9 . Patients childbearing potential ( include female subject female partner male subject ) must use effective method contraception . 1 . Patients without prior histological confirmation primary glioblastoma multiforme . 2 . Patient previous current malignancy site . 3 . Patient receive chemotherapy , radiotherapy study indication , medication antitumor indication prior surgery . 4 . Patient recurrent multiple malignant glioma ( include gliomatosis cerebri ) . 5 . Patient metastatic lesion subtentorial outside calvaria . 6 . Patient receive chemotherapy radiotherapy sensitizer head neck tumor . 7 . Patient receive radiotherapy head neck lead radiotherapy domain overlap . 8 . Frequent vomit medical condition could interfere oral medication intake ( eg , partial bowel obstruction ) . 9 . Known human immunodeficiency virus ( HIV ) positive acquire immune deficiency syndrome ( AIDS ) relate illness . 10 . Woman pregnant breastfeeding . 11 . Patient history hypersensitivity temozolomide analogic alkylating agent . 12 . Patient severe myelosuppression 13 . Patient condition investigator think subject suitable enrolment , like know subject may good compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>prognosis</keyword>
	<keyword>supra-early chemotherapy</keyword>
</DOC>